Search
SKF-96365 free base
go.drugbank.com/drugs/DB17054ExperimentalSKF-96365 is a receptor-mediated calcium entry (RMCE) inhibitor structurally different from other calcium antagonists.[A253132]
Categories: Heterocyclic Compounds, 1-RingSynonyms: 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazoleST101 peptide
go.drugbank.com/drugs/DB17272ExperimentalST101 is a cell-penetrating peptide that disrupts the protein-protein interactions driving ATF5-regulated gene transcription.
AMG 424
go.drugbank.com/drugs/DB17357InvestigationalAMG 424 is a novel, humanized, anti-CD3/CD38 bispecific monoclonal antibody being investigated for multiple myeloma.
Synonyms: Humanized Bi-Specific Xmab(R) T Cell Recruiting Antibody Construct Directed Against Cd3 And Cd38DS-1211
go.drugbank.com/drugs/DB17837InvestigationalDS-1211 is a potent and selective novel small molecule tissue-nonspecific alkaline phosphatase (TNAP) inhibitor.[A259786]
Synonyms: N-Acetyl-R-leucine, ACETYLLEUCINE, (R)-ATX-01
go.drugbank.com/drugs/DB18141InvestigationalATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b (miR-23b).
FBX-101
go.drugbank.com/drugs/DB18340InvestigationalFBX-101 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene
BP-14979
go.drugbank.com/drugs/DB16302InvestigationalBP-14979 is under investigation in clinical trial NCT01785147 (Efficacy and Safety of BP1.4979 in Smoking Cessation).
Apratastat
go.drugbank.com/drugs/DB13020InvestigationalTmi 005 is under investigation in clinical trial NCT00095342 (Study Evaluating TMI-005 in Active Rheumatoid Arthritis).
Categories: Heterocyclic Compounds, 1-RingALLO-715
go.drugbank.com/drugs/DB18640InvestigationalALLO-715 is an allogeneic chimeric antigen receptor T Cell therapy targeting B cell maturation antigen (BCMA).
Synonyms: Allogenic Chimeric Antigen Receptor T Cells Targeting B Cell Maturation Antigen (BCMA)Sacituzumab tirumotecan
go.drugbank.com/drugs/DB18777InvestigationalSacituzumab tirumotecan is a recombinant humanized IgG1 anti-TROP2 monoclonal antibody conjugated to a topoisomerase I inhibitor.